Skip to content

To study the effect of Phalapriyangvadi Churna in worm infestation in children

Single arm clinical study to evaluate the efficacy of Phalapriyangvadi Churna in purishaja krimi. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/066858
Enrollment
30
Registered
2024-05-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B839- Helminthiasis, unspecified

Interventions

None listed

Sponsors

Dr Tejas Manik Bodke
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children age between 2 to 12 years of both male and female gender. 2.The patients presenting the signs and symptoms of krimi such as Vivarnata (Skin Pigmentation),Udarshul (Abd pain),Gudkandu (itching near anal region),MalaVishtambhata (constipation),Aganimandya(Anorexia),Vivarnata (Pityriasis alba) 3.The patients whose parents are ready to participate in the clinical trial by giving informed written consent

Exclusion criteria

Exclusion criteria: 1.Patients having life threatening illness and who is bed ridden. 2.Patients who are known case of chronic systemic illness. 3.Patients having severe abdominal pain & fever.

Design outcomes

Primary

MeasureTime frame
To decrease symptoms of Purishaja Krimi(worm infestation).Timepoint: 7 Days study with followup on 3rd and 7th day (0,3,7 Days)

Secondary

MeasureTime frame
To study the Adverse effect of Phalapriyangvadi Churna,if anyTimepoint: 7 Days study with followup on 3rd and 7th day (0,3,7 Days)

Countries

India

Contacts

Public ContactDr Tejas Manik Bodke

Dr.D.Y.Patil College Of Ayurveda and Research Centre,Sant Tukaram Nagar, Pimpri, Pune

dr.mosim2010@gmail.com7350751503

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026